Tower Research Capital LLC (Trc) Tarsus Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 504 shares of TARS stock, worth $21,949. This represents 0.0% of its overall portfolio holdings.
Number of Shares
504
Previous 485
3.92%
Holding current value
$21,949
Previous $15,000
80.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding TARS
# of Institutions
201Shares Held
40.5MCall Options Held
72.7KPut Options Held
313K-
Black Rock Inc. New York, NY3.27MShares$142 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.24MShares$141 Million2.92% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.53MShares$110 Million5.35% of portfolio
-
Jennison Associates LLC2.5MShares$109 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$98.2 Million9.38% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.16B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...